Brind.

The iShares Nasdaq Biotechnology ETF (IBB) was reported to hold significant shares of Amgen, Vertex Pharmaceuticals, and Gilead Sciences.

9 reports, 3 independent Updated Sep 26
Gone quiet
Reports
9
Developments
2
Repetition
78%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

The iShares Nasdaq Biotechnology ETF (IBB) was reported to hold significant shares of Amgen, Vertex Pharmaceuticals, and Gilead Sciences.

Who's involved

What this event is mainly about
AmgenVertex PharmaceuticalsGilead Sciences

How it developed

Newest first. Tap a step to see who reported it.
  1. Gilead, Vertex, and Amgen are major holdings in the VanEck Biotech ETF.1 source
  2. IBB reported to hold significant shares of Amgen, Vertex Pharmaceuticals, and Gilead Sciences.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
3 more outlets ran the same wire story